Development of a 2D-QSAR Model for Tissue-to-Plasma Partition Coefficient Value with High Accuracy Using Machine
Koichi Handa1, Seishiro Sakamoto2, Michiharu Kageyama3
1Toxicology & DMPK Research Department, Teijin Institute for Bio-Medical Research, Teijin Pharma Limited, 4-3-2 Asahigaoka, Hino-shi, Tokyo, 191-8512, Japan. ko.handa@teijin.co.jp.
This study developed a novel 2D-QSAR model for predicting tissue-to-plasma partition coefficient (Kp) values. The multimodal approach, combining in vitro data and physicochemical descriptors, achieved superior accuracy compared to traditional methods.
Area of Science:
- Pharmacokinetics and Drug Development
- Computational Chemistry
- Quantitative Structure-Activity Relationship (QSAR) studies
Background:
- Physiologically based pharmacokinetic (PBPK) models are increasingly used in new drug applications.
- Tissue-to-plasma partition coefficient (Kp) is a critical PBPK parameter, but experimental determination is challenging.
- In silico methods are sought to overcome experimental limitations in Kp determination.
Purpose of the Study:
- To develop a 2D-QSAR model for predicting Kp values.
- To utilize physicochemical descriptors as explanatory variables, moving beyond in vitro and in vivo parameters.
- To enhance the predictability of Kp values through an improved modeling approach.
Main Methods:
- A 2D-QSAR model was developed using the random forest algorithm.
- Physicochemical descriptors were employed as explanatory variables.
- A multimodal approach combined minimal in vitro experimental data with physicochemical descriptors.
Main Results:
- The developed multimodal 2D-QSAR model demonstrated superior accuracy compared to conventional models.
- The model achieved the highest accuracy, indicated by a low RMSE and high percentage of two-fold error (0.39 and 64.5%).
- Multimodality was confirmed as a beneficial strategy for 2D-QSAR model development.
Conclusions:
- A highly accurate 2D-QSAR model for Kp prediction was successfully developed.
- The model effectively integrates limited in vitro data with physicochemical descriptors.
- This approach offers a promising alternative for estimating Kp values in drug development.
More Related Videos
09:53Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
Published on: August 16, 2020
07:15Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
Published on: August 16, 2020
Related Concept Videos
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological Pharmacokinetic Models: Assumption with Protein Binding
Model Approaches for Pharmacokinetic Data: Compartment Models
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Model Approaches for Pharmacokinetic Data: Physiological Models
Compartment Models: Two-Compartment Model
